Product Description
Mechanisms of Action: Fungi Degrader
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Barrier
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 2: Tinea Versicolor|Pityriasis
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
Dose finding study of R126638 in pityriasis versicolor | P2 |
Completed |
Tinea Versicolor|Pityriasis |
2007-03-01 |